Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
EVERY investment in the portfolio is extraordinarily weak and falls apart like a cheap suit - which explains the near 50% discount to nav. Not a bargain.
--------
So how do you explain the NAV if the portfolio companies are so poor? What a ridiculous argument.
Discount is due to fundraising at 25p, placees offloading, market sentiment and delay in Innovative Eyeware IPO. Case closed.
Has nobody noticed today's second RNS?
I wasn't too bothered about the placing - it's the quickest and cheapest way for the company to raise money and it was possible to buy today at 26p if you feel you missed out. But we're also selling the family silver - 1% of BELL as well as an oversubscribed placing. Surely we don't need to do both? What's the rationale?
The major shareholders bought the Bank loan when it would have been cheaper to buy the outstanding shares. They didn't buy the outstanding shares. What does that suggest to you?
---------
The loan had value, the equity was worthless. Subsequent events have borne this out.
I think Lee is correct - they don't seem to be proposing a share consolidation, just a reduction in nominal value enabling more shares to be issued if the price slips under 1p (hardly encouraging). Conversely they are also looking to create a way of returning capital to shareholders in the future. The question is, which do you think will happen first, a fundraise or a dividend? Not much of a question really.
No point expecting VDTK to get a piece of the action, but the EU is planning a massive expansion of residential solar capacity...
https://ec.europa.eu/commission/presscorner/detail/en/ip_22_3131
Hi all. At the risk of looking like I haven't been paying attention, I have a question...
According to Feeks's research, four companies have won contracts with the JTA, but are they complementary technologies or competitors for Guident? Makes all the difference as far as today's announcement is concerned.
IWeb has finally got its act together. I've been given 45% of the excess application on top of the 1 for 15 allocation. Surprised it's so high but maybe they were a little more generous with the more modest orders? Nearly didn't bother applying with so few shares available but ended up with six times the basic entitlement. How did the rest of you get on?
Still no wiser about the number of excess shares available or how the scale-back will be handled. Could be a simple percentage of each application is allocated, or maybe small orders will be filled completely and larger ones scaled back. In any case it seems unlikely that RedAce has missed out on anything exciting.
Well, since Lucyd pulled their fundraise in order to announce their IPO, it makes sense that TEK would step in to plug the funding gap. I'm much happier to see a placing than further dilution in Lucyd and Salarius via crowdfunding. This additional investment should repay itself many times over in the coming months.
Excellent day all round for FDBK and a relief to get the placing behind us at last. Just remains for the company to capitalize on the opportunities that are opening up on several fronts. One quibble - why go to the administrative headache of involving existing holders then make so few shares available?
Hi coffeecups
Change of broker in August and continuing large share sales suggest a placing soon. £0.7m cash at 31.5.20 plus £5m raised in July 2020 less £2.2m unaudited cash at 31.5.21 gives a burn rate of £300k/mth. Always best to raise funds before the need becomes urgent especially with markets arguably too high. Final results should be out this month if the last two years are anything to go by.
New company overview on website. Neat summary of the business and its advantages over the competition.
https://fbkmed.com/feedback-plc/reports-and-presentations/
Could it be a successful crowdfunding effort behind the sp rise? Closed on 31st July and marked as 'funded' on the page.
https://crowdforangels.com/company/plc/verditek-plc-1054
Negligible or they would have mentioned it. A 'good news' RNS without revenues always gets punished on AIM, hence the drop. On the plus side it did enable me to get a buy order filled at 0.8p - just hope it's the bottom.
Updated on Monday
http://www.alignresearch.co.uk/ascent-resources/moving-initiate-arbitration/
If there were two buys of 25m shares the other day and we've seen a sell of 25m today is it too farfetched to imagine there's a second sell being put through this afternoon? It would explain why so many buys aren't lifting the share price.